JD Health cancels 21.54 million repurchased shares, trimming outstanding stock by 0.67%

Bulletin Express07-22

JD Health International Inc. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 22 July 2026, confirming the cancellation of 21.54 million ordinary shares that had been repurchased between 15 May and 30 June 2026.

The cancellation cut the company’s issued share capital to 3.19 billion shares from 3.21 billion, representing a 0.67% reduction.

Repurchase prices for the cancelled shares ranged from HK$32.05 to HK$45.17 per share. Based on the disclosed volumes and prices, the volume-weighted average repurchase price is calculated at approximately HK$38.92, implying an aggregate consideration of about HK$838.77 million.

Following the share cancellation, the company reported no treasury shares. The disclosure was authorised by Director Dong Cao.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment